Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 68

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 virus gastroenteritis infection EBV HPV NA1 norovirus measles % gb ® type bas-congo ° BN
2 viruses outbreaks KSHV latent types dobrava GI vaccines FOSCC L1 nanoparticles 3 tibrovirus acuminatum VZV
3 herpes df‐edu cells NPC cervical syndrome bat carnation beta-lactoglobulin 3hp-β-lg tanguticum 2 bas-congo virus bowenoid papulosis IDE
4 antiviral astrovirus cell epstein-barr cancer mice GII MV bovine 3A puumala virus polio tibroviruses < BNP
5 simplex gastrointestinal IFITM1 carcinoma cervical cancer HCPS nano-7 vaccine alpha-lactalbumin hpv l1 protein serotypes c-cyd ekpoma condyloma acuminatum cell-free
6 cytomegalovirus astroviruses expression ebv infection HPV16 haemophagocytic kit measles virus feline spikes r. tanguticum ce-cyd experiments telomerase activity tlas
7 activity parechovirus RPEC malignancies papillomaviruses saaremaa detection measles vaccines milk gb 3a viruses R. ppnt BASV papulosis ge
8 respiratory patients vitro epstein hpvs particles fnov developed lactoferrin loop assay eradication saffold anogenital ncp7
9 influenza diarrhea study EBER2 E7 electron nanobodies vaccination 0 protein nov. CTP virus bowenoid postulated
10 CMV family host nasopharyngeal carcinoma specific microscopy 2′FL RNA 0/9 region CV-B5 cpnt vesiculoviral condyloma NHNP
11 infections foodborne lytic EBER1 CTL HFRS cathepsin attenuated methylated immature puumala cytocidal vesiculoviruses telomerase B6RA
12 HSV TK bear latency high-risk enteric rate HPV16L1 murine cross-neutralising enterovirus pv(pv myocardium 65 vitamin
13 HIV viral observed epstein-barr virus E6 virus-like noroviruses protective adenovirus mabs raised poliovirus saffold virus 0.001 pyridoxylidenephloroglucinol
14 parainfluenza recognized entry diseases D4 faecal loopamp kit CERV presence fusion polyclonal global glycoproteins mrna zinc
15 herpes simplex virus human suggest nasopharyngeal cancers hantaviruses loopamp 18L1 toilets conformation antibodies enzyme humans heating virus
16 • enteroviruses antigen burkitt papillomavirus hantavirus nano-94 morbillivirus casein capsid products dna viruses animals = human
17 immunodeficiency parechovirus a inhibit lymphomas strains haemophagocytic syndrome PEC strain teno structural derived cyd branch skin neurons
18 HSV-1 implicated mir-36 humanized e7 proteins NA2 analysis virus environmental HPV basal pv(pv)(wt sweetwater encephalomyocarditis maintained
19 HCMV pathogens kaposi lead peptide oxide showed live chemically postfusion A71 reo coastal SV‐40 cell-to-cell spread
20 retinal common P-PMO therapeutics variants nitric FCV high-titres surfaces FG ethanol pv(pv)(sabin bivens encephalomyocarditis virus theoretical
21 zoster patient in vivo lymphoproliferative hpv strains 27-nm norovirus gi CRSV HNSCC cross-reactive enterovirus a71 IFITM plains iaps chloride
22 HHV-6 coronaviruses in vitro infectious mononucleosis medical pre-infection btcalv/a10/usa/2009 CVMV torque suggesting gen. endgame tibrogargan c-myc assemblies
23 hepatitis assays virus infection mononucleosis warts SPIEM nov carmv modified icosahedral cretaceous vesicular stomatitis obtained 103 hydrogen
24 7 revealed host cell EBNA1 isolates nitric oxide caliciviruses measles vaccine inhibited crystal structure immunohistochemistry PV cardioviruses sec reactivate
25 proved labeling gammaherpesvirus tumors 16 norwalk M49 petal samples hpv infection coxsackievirus sindbis hill activity biological activities
26 viral infections tract PEL population response newbury detection rate morbilliviruses oral charged family picornaviridae catechols rhabdoviruses 90 cell-associated
27 drugs enteric viruses neurological associated with humankind inoculated nano-62 million research inter-genotype cross‐reacted orthomyxo vesiculovirus similarities ganglia
28 compounds — ability proteins consistently distinct histo-blood group antigens pistil methods crystal atherinum keratinocytes isolate theiler cellular receptor
29 pme-5-azac outbreak herpesvirus genetic 52 electron microscopy HBGA stamen murine norovirus capsid protein immunofluorescence keeping nonhuman primate recombinant virus (4′rs)-4′-chloro-1′,4′-dihydrobananin
30 varicella zoster virus incorporation protein barr cutaneous optimal MNV vaccaria milk proteins prefusion indirect immunofluorescence assay (−)RNA midge-borne ml bananin
31 1 HSV‐1 significantly epithelial divergent identification bats biothreat agent esterified psv progressive type 2 experimental data bean cell-to-cell
32 herpesvirus cosavirus vivo lymphoma human papillomaviruses allowed inhibition CIRV torque teno virus recognised scalpellinae pox boa S6 pyridoxal
33 human disease tissue studies HPV18 viremia calicivirus leaf 3-hydroxyphthalic vaccine-induced qrt-pcr antigenicity biting normal skin B6
34 herpes simplex virus type 1 members sarcoma humanized mice polyomaviruses unrelated potential total transcriptase structure tests (+)rna viruses TIBV TCID(50 impaired
35 prodrugs infect RTA LMP1 cacx cardiopulmonary similar mottle aerosol triple migdoscalpellum UTP beatrice apoptosis rna virus
36 acid hepatitis black discuss closely faecal samples capsid immunogenic pvs positively polyclonal antibodies restriction tiger describes spread
37 B3 illnesses LANA natural recombinant preparations pocket ovary aichi display 10min dcyd EKV-1 vesicular stomatitis virus HIV-1
38 RPE shellfish DPOL 4 related hantavirus cardiopulmonary syndrome 3c-like CLV sequencing spike ICP4 dthd SWBV theiler's murine encephalomyelitis virus receptor
39 ciliata viral gastroenteritis gene immune induce bovine endosome ringspot source fully virkon countries EKV-2 isoxazoles unusual
40 echovirus herpesviridae viral present species calicivirus GIV biothreat 689 deficit enterovirus infections synthetase BAV expressions considerations
41 approved hiv-infected DNA lymphohistiocytosis traditionally agent bind pre-existing oral mucosa antibodies halamid-d ad5 animal species XIAP rna-binding
42 presentation gastrointestinal tract role animal model epithelia particle LAMP produced april epitopes clidox hpv16 infection partially relevant sars-associated
43 esters years including encode term 1.34 regions commercial aichi virus entry belonging converts phylogenetic analyses c-iap2 ribavirin
44 pmeo-dapy nervous CVB rnas maintenance composition RT‐LAMP current monitoring previously times correlation rat c-iap1 subsequently
45 improved oysters pel cells post-transplant account purified 2009 high lactoferrampin particles morphological (±)RNA individual mengo oxidation
46 injury challenge RP1 transient malignant 49.4 genogroups neutralizing cleaning major phylogeny urd predict vaccinia condensation
47 hepatotropic SRSV days EBV- avoided dysfunction x-ray world squamous wild-type virus inactivating OMP viral hemorrhagic fever levels prospect
48 rivularis stool class LMP2 decided survived vulnerable immunity molluscan U. denatured broad-spectrum mosquito cells expression insulin-degrading
49 HCV management herpesvirus infection autoimmune diseases refers HTNV emerging highly virocap DE shown (+)RNA solely virus progenitor
50 hepatitis b virus immune electron microscopy block humoral immune responses HPV31 heterogeneity genotype tissues 22 directed effective rhabdo postulates tumors downregulation